LAWRENCE, Mass., March 20, 2014 /PRNewswire/ -- To build
awareness for National Kidney Month, NxStage Medical, Inc. (Nasdaq:
NXTM), a leading manufacturer of innovative dialysis products,
today announced the first annual National Home Hemodialysis Day
taking place today, March 20, 2014.
In partnership with local and national kidney patient
organizations, NxStage is encouraging the more than 26 million
Americans1 that may have kidney disease and their
supporters to wear a green ribbon to spread the word about kidney
disease treatment options including home hemodialysis. In
conjunction with this campaign, the Company is launching a national
patient-to-patient outreach program called NxStage® + One™. This
innovative initiative is based on the premise that one-to-one
communication is the most compelling way to spread the word about
the benefits of home hemodialysis.
"The goal of NxStage + One is to bring patients together and
have them interact one-on-one in a grassroots way to educate and
inspire each other," said Joe Turk,
President of NxStage Medical, Inc. "National Home Hemodialysis Day
gives us a platform for educating our patients and other kidney
disease patients about the significant benefits home hemodialysis
may make in their lives."
NxStage is establishing National Home Hemodialysis Day to
increase awareness of the health and lifestyle benefits possible
with home hemodialysis treatment with the nearly
430,0002 Americans who are currently receiving dialysis
treatment, their care partners, families and medical professionals.
The Company is sending green ribbons to its wide network of
patients, care partners, and kidney support communities throughout
this month to raise awareness of this potentially life changing
therapy option. In addition, NxStage is asking patients and care
partners to share their inspiring stories, videos and photos on
social media channels using the hashtag, #HomeHemodialysisDay.
NxStage patients will be featured on the Company's website during
the month of March.
"The National Kidney Foundation believes that patients should be
educated about all available treatment options so they can select
the modality that best suits their lifestyle. National Kidney Month
is a perfect time for patients to learn more and for their family
members and others at risk to get their kidneys checked," said Dr.
Beth Piraino, President of the
National Kidney Foundation.
To find out where NxStage will be holding regional NxStage + One
sessions or to receive a green ribbon for National Home
Hemodialysis Day, visit www.nxstage.com.
About the NxStage System One™
The NxStage System One is the first and only truly portable
hemodialysis system cleared for home use by the U.S. Food &
Drug Administration (FDA). Its simplicity and revolutionary size
(just over a foot tall) are intended to allow convenient use in
patients' homes and give patients the freedom to travel with their
therapy. When combined with the NxStage Pureflow SL Dialysis
Preparation System, patients are able to further simplify, using
ordinary tap water to create dialysis fluid on demand. Unlike
conventional hemodialysis systems, the System One requires no
special infrastructure to operate. Under the guidance of their
physician, patients can use the NxStage System One, with their
trained partners, where, how and when it best meets their needs -
at home or on vacation and at a medically appropriate treatment
frequency. www.nxstage.com.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq:
NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
ESRD and acute kidney failure. For more information on NxStage and
its products, please visit the Company's website at
www.nxstage.com.
About The National Kidney Foundation
The
National Kidney Foundation is the leading organization in the U.S.
dedicated to the awareness, prevention and treatment of kidney
disease for hundreds of thousands of healthcare professionals,
millions of patients and their families and tens of millions of
Americans at risk. For more information, visit
kidney.org.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. Actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors including those that are
discussed in NxStage's filings with the Securities and Exchange
Commission, including the Annual Report on Form 10-K for the year
ended December 31, 2013. NxStage is
under no obligation to (and expressly disclaims any such obligation
to) update or alter its forward-looking statements, whether as a
result of new information, future events or otherwise.
Media Contact:
Kristen K.
Sheppard, Esq., VP, Investor Relations
ksheppard@nxstage.com
978-332-5923
1, 2 National Kidney Foundation © 2013 National
Kidney Foundation, Inc.
Video -
http://origin-qps.onstreammedia.com/origin/multivu_archive/PRNA/ENR/FX-NY86093-20140320-1.mp4
Logo - http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
SOURCE NxStage Medical, Inc.